Questions discussed in this category
Individual times in the therapeutic range while on VKA treatment was not registered in FRAIL-AF.
In FRAIL-AF, switching VKA therapy to a NOAC was associated with higher risk of bleeding in elderly, frail patients.
In FRAIL-AF, participants were switched from VKA to dabigatran, rivaroxaban, apixaban, and edoxaban.
176731789217692176931312511875
Papers discussed in this category
Cancer causes & control : CCC, 2010-03
Atherosclerosis, 2001-06
The American journal of clinical nutrition, 2008-10
Circulation. Cardiovascular genetics, 2008-12
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012-01
Human genetics, 2012-05
PeerJ, 2013
Nature, 2016-08-18
Am J Hum Genet, 1998 May
Am J Reprod Immunol, 2011 Jan 18
Am J Reprod Immunol, 2012 Aug 06
BMC Cancer, 2008 Nov 07
BMJ Case Rep, 2012 Nov 15
BMJ Case Rep, 2013 Jun 13
Mol Biol Rep, 2010 Jun 08
Mol Biol Rep, 2010 Nov 16
Nat Genet, 2008 Jul
Proc Natl Acad Sci U S A, 2001 Mar 13
Mol Biol Rep, 2018 Mar 29
Transfus Apher Sci, 2014 Jan 08
J Matern Fetal Neonatal Med, 2015 Jul 02
Clin Neurol Neurosurg, 2013 Mar 21
J Hum Genet, 2006 Feb 18
Circulation, 2023 Aug 27